• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名患有溃疡性结肠炎和原发性硬化性胆管炎的HIV阴性肝移植受者新发卡波西肉瘤

De Novo Kaposi Sarcoma in an HIV-Negative Liver Transplant Recipient With Ulcerative Colitis and Primary Sclerosing Cholangitis.

作者信息

Ramakrishnan Pavithra, Amin Khalid, Gaertner Wolfgang, Aby Elizabeth S

机构信息

Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.

Department of Pathology, University of Minnesota, Minneapolis, Minnesota, USA.

出版信息

Case Rep Transplant. 2024 Nov 12;2024:4699128. doi: 10.1155/crit/4699128. eCollection 2024.

DOI:10.1155/crit/4699128
PMID:39624666
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11611400/
Abstract

De novo or viral reactivation cancers are a major cause of morbidity and mortality in the solid organ transplant (SOT) population. Primary sclerosing cholangitis (PSC) is an aggressive disease which can lead to cholestatic liver damage and cirrhosis. PSC often cooccurs with inflammatory bowel disease (IBD). Here, we describe the case of a 28-year-old male with PSC along with poorly controlled IBD who underwent a liver transplant and developed colonic Kaposi sarcoma (KS). Our case highlights the importance of adequate pretransplant screening for endemic viruses, high clinical suspicion for KS in the setting of difficult-to-control colitis, and early multidisciplinary involvement.

摘要

新发或病毒再激活引发的癌症是实体器官移植(SOT)人群发病和死亡的主要原因。原发性硬化性胆管炎(PSC)是一种侵袭性疾病,可导致胆汁淤积性肝损伤和肝硬化。PSC常与炎症性肠病(IBD)同时出现。在此,我们描述了一名28岁男性的病例,该患者患有PSC以及控制不佳的IBD,接受了肝移植并发生了结肠卡波西肉瘤(KS)。我们的病例强调了移植前对地方性病毒进行充分筛查的重要性、在难以控制的结肠炎背景下对KS保持高度临床怀疑以及早期多学科参与的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ebb/11611400/231645ceb6ec/CRIT2024-4699128.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ebb/11611400/c0df94ae7981/CRIT2024-4699128.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ebb/11611400/a23f03744635/CRIT2024-4699128.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ebb/11611400/ab6509139244/CRIT2024-4699128.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ebb/11611400/231645ceb6ec/CRIT2024-4699128.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ebb/11611400/c0df94ae7981/CRIT2024-4699128.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ebb/11611400/a23f03744635/CRIT2024-4699128.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ebb/11611400/ab6509139244/CRIT2024-4699128.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ebb/11611400/231645ceb6ec/CRIT2024-4699128.004.jpg

相似文献

1
De Novo Kaposi Sarcoma in an HIV-Negative Liver Transplant Recipient With Ulcerative Colitis and Primary Sclerosing Cholangitis.一名患有溃疡性结肠炎和原发性硬化性胆管炎的HIV阴性肝移植受者新发卡波西肉瘤
Case Rep Transplant. 2024 Nov 12;2024:4699128. doi: 10.1155/crit/4699128. eCollection 2024.
2
Clinical aspects and prognosis of patients with inflammatory bowel disease associated with autoimmune liver diseases.炎症性肠病相关自身免疫性肝病患者的临床特征和预后。
Gastroenterol Hepatol. 2022 Feb;45(2):83-90. doi: 10.1016/j.gastrohep.2021.03.011. Epub 2021 May 20.
3
What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?在土耳其患者中,原发性硬化性胆管炎与性别及炎症性肠病之间有何关联?
Hepatogastroenterology. 1998 Nov-Dec;45(24):2064-72.
4
Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases.维得利珠单抗治疗原发性硬化性胆管炎和炎症性肠病患者的效果。
Clin Gastroenterol Hepatol. 2020 Jan;18(1):179-187.e6. doi: 10.1016/j.cgh.2019.05.013. Epub 2019 May 14.
5
Evolving strategies to reduce colectomy rates in primary sclerosing cholangitis-inflammatory bowel disease: clinical remission of corticosteroid refractory colitis post-liver transplant with vedolizumab.降低原发性硬化性胆管炎合并炎症性肠病结肠切除率的不断演变策略:维得利珠单抗治疗肝移植后皮质类固醇难治性结肠炎的临床缓解
Frontline Gastroenterol. 2016 Oct;7(4):271-274. doi: 10.1136/flgastro-2016-100711. Epub 2016 Aug 5.
6
Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.原发性硬化性胆管炎的原位肝移植:单中心12年经验
Ann Surg. 1997 May;225(5):472-81; discussion 481-3. doi: 10.1097/00000658-199705000-00004.
7
Interactions between primary sclerosing cholangitis and inflammatory bowel disease: implications in the adult liver transplant setting.原发性硬化性胆管炎与炎症性肠病的相互作用:对成人肝移植环境的影响。
Expert Rev Gastroenterol Hepatol. 2017 Oct;11(10):949-960. doi: 10.1080/17474124.2017.1343666. Epub 2017 Jun 21.
8
[PSC-IBD: specific phenotype of inflammatory bowel disease associated with primary sclerosing cholangitis].[原发性硬化性胆管炎相关炎症性肠病的特定表型]
Vnitr Lek. 2018 Summer;64(6):659-664.
9
A protective effect of inflammatory bowel disease on the severity of sclerosing cholangitis.炎症性肠病对硬化性胆管炎严重程度的保护作用。
Front Immunol. 2024 Mar 6;15:1307297. doi: 10.3389/fimmu.2024.1307297. eCollection 2024.
10
Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.原发性硬化性胆管炎中独特的炎症性肠病表型。
World J Gastroenterol. 2015 Feb 14;21(6):1956-71. doi: 10.3748/wjg.v21.i6.1956.

本文引用的文献

1
Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)-A European Society of Organ Transplantation (ESOT) Consensus Statement.原发性硬化性胆管炎(PSC)伴或不伴炎症性肠病(IBD)的肝移植-欧洲器官移植学会(ESOT)共识声明。
Transpl Int. 2023 Sep 29;36:11729. doi: 10.3389/ti.2023.11729. eCollection 2023.
2
Colectomy in patients with ulcerative colitis is not associated to future diagnosis of primary sclerosing cholangitis.溃疡性结肠炎患者行结肠切除术与未来原发性硬化性胆管炎的诊断无关。
United European Gastroenterol J. 2023 Jun;11(5):471-481. doi: 10.1002/ueg2.12388. Epub 2023 May 11.
3
[Kaposi sarcoma-a complication of treatment refractory ulcerative colitis].
[卡波西肉瘤——治疗难治性溃疡性结肠炎的一种并发症]
Pathologie (Heidelb). 2022 Sep;43(5):372-376. doi: 10.1007/s00292-022-01090-4. Epub 2022 Jun 24.
4
De Novo Malignancy After Liver Transplantation: Risk Assessment, Prevention, and Management-Guidelines From the ILTS-SETH Consensus Conference.肝移植后新发恶性肿瘤:风险评估、预防和管理——ILTS-SETH 共识会议指南。
Transplantation. 2022 Jan 1;106(1):e30-e45. doi: 10.1097/TP.0000000000003998.
5
Current and Future Tools for Diagnosis of Kaposi's Sarcoma.卡波西肉瘤诊断的现有及未来工具
Cancers (Basel). 2021 Nov 25;13(23):5927. doi: 10.3390/cancers13235927.
6
Iatrogenic Kaposi's sarcoma unmasked by Vedolizumab in a patient with ulcerative colitis and well-controlled human immunodeficiency virus: A case report.维多珠单抗暴露的医源性卡波西肉瘤:1例溃疡性结肠炎合并人类免疫缺陷病毒控制良好患者的病例报告
Int J Crit Illn Inj Sci. 2021 Jul-Sep;11(3):177-180. doi: 10.4103/IJCIIS.IJCIIS_92_20. Epub 2021 Sep 25.
7
Human herpesvirus 8 and Kaposi sarcoma: how should we screen and manage the transplant recipient?人疱疹病毒 8 与卡波西肉瘤:我们应该如何对移植受者进行筛查和管理?
Curr Opin Infect Dis. 2021 Dec 1;34(6):646-653. doi: 10.1097/QCO.0000000000000792.
8
Inflammatory bowel disease course in liver transplant versus non-liver transplant patients for primary sclerosing cholangitis: LIVIBD, an IG-IBD study.肝移植与非肝移植的原发性硬化性胆管炎患者的炎症性肠病病程:LIVIBD,一项炎症性肠病研究。
Dig Liver Dis. 2021 Jun;53(6):712-716. doi: 10.1016/j.dld.2020.09.011. Epub 2020 Sep 21.
9
Human herpesvirus 8-associated colonic Kaposi's sarcoma during vedolizumab treatment in ulcerative colitis: a case report and review of the literature.人疱疹病毒 8 相关的结肠卡波西肉瘤在溃疡性结肠炎中使用维多珠单抗治疗:病例报告及文献复习。
BMC Gastroenterol. 2020 Mar 24;20(1):76. doi: 10.1186/s12876-020-01221-2.
10
Management of Kaposi sarcoma after solid organ transplantation: A European retrospective study.实体器官移植后卡波西肉瘤的管理:一项欧洲回顾性研究。
J Am Acad Dermatol. 2019 Aug;81(2):448-455. doi: 10.1016/j.jaad.2019.03.028. Epub 2019 Mar 19.